Date
- Tuesday, 19 October 2010
Location
- European Medicines Agency, Amsterdam, the Netherlands
The information day will address the following areas: Changes in the EU regulatory environment in relation to clinical trials; The new pharmaceutical legislation and the impact on the conduct of pharmacovigilance in the EU; The new data quality management in EudraVigilance and impact on stakeholders; Practical implementation questions from stakeholders with focus on electronic reporting of ICSRs and pharmacovigilance. Panel discussions will provide the opportunity for extensive Q&As with the speakers, chairpersons and Programme Committee members.